METHYLCHROMONYL LINKED BENZYLIDENES AS NOVEL PARTIAL PPARγ AGONISTS: SYNTHESIS, CHARACTERIZATION AND DOCKING STUDIES (original) (raw)
Benzisoxazole containing Thiazolidinediones as Peroxisome Proliferator Activated Receptor-γ Agonists : Design , Molecular Docking , Synthesis & anti-diabetic studies
Shriram Purohit
2014
View PDFchevron_right
Novel Benzylidene Thiazolidinedione Derivatives as Partial PPARγ Agonists and their Antidiabetic Effects on Type 2 Diabetes
Ashok Pattnaik
Scientific Reports, 2017
View PDFchevron_right
New 2-Aryloxy-3-phenyl-propanoic Acids As Peroxisome Proliferator-Activated Receptors α/γ Dual Agonists with Improved Potency and Reduced Adverse Effects on …
Antonio Lavecchia
Journal of medicinal …, 2009
View PDFchevron_right
Design, synthesis, molecular docking, and in vitro antidiabetic activity of novel PPARγ agonist
Prof. Sunita Malhotra
Monatshefte für Chemie - Chemical Monthly, 2018
View PDFchevron_right
Design and synthesis of non-TZD peroxisome proliferator-activated receptor γ (PPARγ) modulator
Amrutha Nair
Medicinal Chemistry Research, 2014
View PDFchevron_right
A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: Design and synthesis of benzylpyrazole acylsulfonamides
Junichi Sakamoto
Bioorganic & Medicinal Chemistry, 2012
View PDFchevron_right
[4-(2H-1,2,3-Benzotriazol-2-yl)phenoxy]alkanoic Acids as Agonists of Peroxisome Proliferator-Activated Receptors (PPARs)
Jean-Charles Fruchart
Chemistry & Biodiversity, 2006
View PDFchevron_right
A New Class of Peroxisome Proliferator-activated Receptor Agonists with a Novel Binding Epitope Shows Antidiabetic Effects
Timothy Phillips
Journal of Biological Chemistry, 2004
View PDFchevron_right
Rational design and synthesis of some PPAR-g agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones
Dr. Animeshchandra haldar
View PDFchevron_right
Design, synthesis and computational validation of novel benzimidazole/indole-based PPARα and PPARγ partial agonists
Raman Verma
Journal of Chemical Sciences, 2013
View PDFchevron_right
Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013)
Bonggi Lee
Oncotarget, 2017
View PDFchevron_right
New 2-Aryloxy-3-phenyl-propanoic Acids As Peroxisome Proliferator-Activated Receptors α/γ Dual Agonists with Improved Potency and Reduced Adverse Effects on Skeletal Muscle Function
Fernando Mazza
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
In-silico Analysis of Phenyl Propanoic Acid Derivatives to Design Potent Peroxisome Proliferator-activated Receptor (PPAR) Dual Agonists for Type 2 Diabetes mellitus Therapy
Usha Chouhan
Oriental Journal of Chemistry, 2018
View PDFchevron_right
Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs
Neelaveni Thangavel
International Journal of Medicinal Chemistry, 2017
View PDFchevron_right
Novel 1,3-dicarbonyl compounds having 2(3H)-benzazolonic heterocycles as PPARγ agonists
Philippe Chavatte
Bioorganic & Medicinal Chemistry, 2006
View PDFchevron_right
Revisiting glitazars: Thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents
suresh giri
Bioorganic & Medicinal Chemistry Letters, 2011
View PDFchevron_right
IN SILICO DESIGN OF QUINOXALINE BEARING THIAZOLIDINONE DERIVATIVES AS PPARγ AGONIST IN DIABETES MELLITUS
Asian Journal of Pharmaceutical and Clinical Research Journal
Asian Journal of Pharmaceutical and Clinical Research, 2021
View PDFchevron_right
Design and Synthesis of α-Aryloxy-α-methylhydrocinnamic Acids: A Novel Class of Dual Peroxisome Proliferator-Activated Receptor α/γ Agonists
Gregory Stephenson
Journal of Medicinal Chemistry, 2004
View PDFchevron_right
Thiazolidine-2,4-diones derivatives as PPAR-c agonists: Synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-c gene expression
hinna hamid
View PDFchevron_right
Pharmacoinformatic Studies on 4-Thiazolyl-phenoxy Tail Containing Indanyl Acetic Acid Derivatives as PPAR-Pan Agonists as Potent Anti-Diabetic Agent
Usha Chouhan
Indian Journal of Pharmaceutical Education and Research, 2019
View PDFchevron_right
Indanylacetic Acid Derivatives Carrying 4-Thiazolyl-phenoxy Tail Groups, a New Class of Potent PPAR α/γ/δ Pan Agonists: Synthesis, Structure−Activity Relationship, and In Vivo Efficacy
fernando dela cruz
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Design and Synthesis of N -[(4-Methoxyphenoxy)carbonyl]- N -[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist with Efficacious Glucose and Lipid-Lowering Activities
Rajasree Golla, Ramakrishna Seethala
Journal of Medicinal Chemistry, 2005
View PDFchevron_right
Synthesis and Biological Evaluation of Some Novel PPAR-γ agonists for the Management of Type II Diabetes
Sumeet Prachand
2013
View PDFchevron_right
Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome
W. Li
Expert Opinion on Therapeutic Targets, 2017
View PDFchevron_right
Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies
David Ugwu
Lipids in Health and Disease
View PDFchevron_right
Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice
Min Hi Park
PloS one, 2013
View PDFchevron_right
Novel Bisaryl Substituted Thiazoles and Oxazoles as Highly Potent and Selective Peroxisome Proliferator-Activated Receptor δ Agonists
Cow Cow
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Benzoxazinones as human peroxisome proliferator activated receptor gamma (PPARγ) agonists: A docking study using glide
meenu dhanawat
Indian Journal of Pharmaceutical Sciences, 2011
View PDFchevron_right
Novel biphenylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) δ selective antagonists
Hiroyuki Miyachi
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Design and synthesis of a novel class of dual PPARγ/δ agonists
Eric Lamar
Bioorganic & Medicinal Chemistry Letters, 2007
View PDFchevron_right
Design and synthesis of 6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid derivatives as PPARγ activators
Amit Mittal
Bioorganic & Medicinal Chemistry Letters, 2007
View PDFchevron_right
Medicinal Chemistry and Actions of Dual and Pan PPAR Modulators 2011
Abdu Adem
View PDFchevron_right
New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression
Antonio Lavecchia
View PDFchevron_right
Synthesis, in vitro and in silico studies of a PPARγ and GLUT-4 modulator with hypoglycemic effect
Samuel Estrada-Soto
Bioorganic & Medicinal Chemistry Letters, 2014
View PDFchevron_right
Development of a novel class of peroxisome proliferator-activated receptor (PPAR) gamma ligands as an anticancer agent with a unique binding mode based on a non-thiazolidinedione scaffold
Keisuke Yamamoto
Bioorganic & Medicinal Chemistry, 2019
View PDFchevron_right